59 results
Page 2 of 3
6-K
EX-99.1
oxnb svwikqu
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-10.1
2iqednbdfwlwi
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
urrw8izzd0 wm1r4hx
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K/A
EX-99.1
yg81w9yk
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K/A
EX-99.2
27nipbau
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K
EX-99.1
gy4cd9 z2
16 Sep 20
Enlivex Announces Allowance of New Chinese Patent Covering Allocetra Immunotherapy
8:02am
6-K
EX-99.1
wqsw2xbm82im3qx
25 Aug 20
Enlivex Announces Allowance of New U.S. Patent Covering Allocetra Immunotherapy
8:02am
6-K
EX-99.2
ggwt8t
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.1
oo8liqv 7mvdav048
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.1
m6at1zqzqe sw39ui
18 Jun 20
Enlivex Announces Allowance of New Japanese Patent Application Covering ALLOCETRA Immunotherapy
8:32am
6-K
EX-99.1
fx9 yvtahd5ovy
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.2
lj6ekapbsx 5kcmu
18 May 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
ms0b7sf2e4 t502
18 May 20
Condensed Consolidated Financial Statements
4:30pm
424B5
of0rg4hdggr23jys89
3 Mar 20
Prospectus supplement for primary offering
5:13pm
424B5
deww5i0o44vlhmmrmt
26 Feb 20
Prospectus supplement for primary offering
8:23am
6-K
EX-99.1
w04xv4
24 Feb 20
Report of Foreign Private Issuer
6:30am
424B5
90fia65rd5 f9hk
20 Nov 19
Prospectus supplement for primary offering
4:46pm
6-K
EX-99.1
o7uqe2kb3go 43boe
14 Nov 19
Condensed Consolidated Financial Statements
7:30am